Ayo’s role is crucial in providing valuable insights to our clients. With her extensive knowledge of secondary claims data and analytical background, she will play a key role in delivering relevant information. Not only will she contribute to the growth of the business, but she will also build strong and meaningful connections with KMK’s clients.
Prior to joining KMK, Ayo held significant positions in consulting and analytics vendors, where she honed her expertise in analytics. As a Senior Director of Real-World Evidence at IPM.ai, a leader in artificial intelligence and machine learning technologies, she spearheaded the development and implementation of methodologies for patient-level claims data engagements and advanced analytics.
Her focus was on leveraging AI/ML projects to reveal valuable insights and real-world evidence, particularly for early detection of rare and elusive diseases and analysis of treatment patterns. She also played a pivotal role in creating integrated analytical solutions that encompassed social, search, digital, and patient data.
“Ayo’s extensive knowledge and expertise in Pharma consulting and patient analytics will fortify our capabilities and enhance the value we deliver to our clients,” says Jing Yu, Principal of Commercial Analytics & Operations.
With a proven track record at industry-leading companies IQVIA, Symphony Health, and EY, Ayo is primed to revolutionize KMK’s ability to provide state-of-the-art analytics and operational excellence to their clients and make a remarkable difference in improving patient lives.